Gonadorelin vs Hexarelin
A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
Gonadorelin
Synthetic form of endogenous gonadotropin-releasing hormone (GnRH) that stimulates LH and FSH release from the anterior pituitary. Used in TRT protocols to maintain testicular function and prevent atrophy during exogenous testosterone administration. Preserves spermatogenesis and endogenous testosterone production capacity.
Full profileHexarelin
Hexarelin is a potent synthetic hexapeptide GHRP (Growth Hormone-Releasing Peptide) that stimulates GH release via the ghrelin receptor. It produces among the highest GH pulses of any GHRP, but also elevates cortisol and prolactin — a trade-off that distinguishes it from more selective options like Ipamorelin.
Full profile| Gonadorelin | Hexarelin | |
|---|---|---|
| Category | Performance & Growth Hormone | Performance & Growth Hormone |
| Also known as | GnRH, gonadotropin-releasing hormone, Factrel, Lutrepulse | Examorelin, EP 23905, MF-6003 |
| Evidence | Research-stage | Preclinical only |
| Dosing range | 50mcg–200mcg mcg, 2–3x per week subcutaneous | 50mcg–200mcg mcg, 1–3x daily (cycling recommended to prevent desensitization) |
| Administration | Subcutaneous injection, Intranasal (pulsatile delivery) | Subcutaneous injection, Intramuscular injection |
| Key side effects | Injection site reactions, Headache, Nausea, Flushing | Cortisol elevation, Prolactin elevation, Water retention, Increased appetite |
| Cited sources | 2 references | 1 reference |
Key differences
- Evidence level differs: Gonadorelin is research-stage, while Hexarelin is preclinical only.
- Administration: Gonadorelin — Subcutaneous injection, Intranasal (pulsatile delivery); Hexarelin — Subcutaneous injection, Intramuscular injection.
- Frequency: Gonadorelin is typically 2–3x per week subcutaneous; Hexarelin is 1–3x daily (cycling recommended to prevent desensitization).
- Research depth: this profile cites 2 sources for Gonadorelin vs 1 for Hexarelin.
How each works
Gonadorelin
Gonadorelin directly binds GnRH receptors in the anterior pituitary to trigger LH and FSH secretion, which in turn stimulates Leydig cells for testosterone production and maintains spermatogenesis. Used as a TRT adjunct, pulsatile gonadorelin administration mimics natural hypothalamic GnRH to prevent testicular suppression associated with exogenous androgen use.
Hexarelin
Hexarelin produces dose-dependent GH release significantly greater than GHRP-6 or Ipamorelin. It also has direct cardioprotective effects via CD36 receptor binding, independent of GH — making it unique among GHRPs. Studies show protection from ischemic cardiac injury and myocardial fibrosis reduction in animal models. Desensitization occurs with chronic continuous use.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.